1. Setting Priorities in Global Child Health Research Investments: Guidelines for Implementation of CHNRI Method
- Author
-
Igor Rudan, Jennifer L. Gibson, Shanthi Ameratunga, Shams El Arifeen, Zulfiqar A. Bhutta, Maureen Black, Robert E. Black, Kenneth H. Brown, Harry Campbell, Ilona Carneiro, Kit Yee Chan, Daniel Chandramohan, Mickey Chopra, Simon Cousens, Gary L. Darmstadt, Julie Meeks Gardner, Sonja Y. Hess, Adnan A. Hyder, Lydia Kapiriri, Margaret Kosek, Claudio F. Lanata, Mary Ann Lansang, Joy Lawn, Mark Tomlinson, Alexander C. Tsai, Jayne Webster, Igor Rudan, Jennifer L. Gibson, Shanthi Ameratunga, Shams El Arifeen, Zulfiqar A. Bhutta, Maureen Black, Robert E. Black, Kenneth H. Brown, Harry Campbell, Ilona Carneiro, Kit Yee Chan, Daniel Chandramohan, Mickey Chopra, Simon Cousens, Gary L. Darmstadt, Julie Meeks Gardner, Sonja Y. Hess, Adnan A. Hyder, Lydia Kapiriri, Margaret Kosek, Claudio F. Lanata, Mary Ann Lansang, Joy Lawn, Mark Tomlinson, Alexander C. Tsai, and Jayne Webster
- Abstract
This paper provides detailed guidelines for implementation of systematic method for setting priorities in health research investments that was recently developed by Child Health and Nutrition Research Initiative (CHNRI). The target audience for the proposed method are primarily public donors and not-for-profit foundations and international agencies, although it can also be used by private sector. It is a process that involves the investors, technical experts and numerous other stakeholders, and results in: (i) understanding and defining the context in which investments are performed; (ii) agreeing on expected “returns” on the investments and risk preferences; (iii) defining the main criteria for priority setting; (iv) systematic listing of many competing research investment options; (v) transparent valuation of each research option against each criterion; (vi) adjustment of this valuation according to values of the society; (vii) combining this adjusted valuation with predicted cost, expected “returns” and risk preferences to decide on the optimal investment strategy. “Returns” on the investments can be defined as reduction in existing disease burden (public and not-for-profit sector) or patentable products (private sector). The CHNRI methodology is a flexible process that enables prioritising health research investments at any level: institutional, regional, national, international or global. This paper presents detailed guidelines for application of the CHNRI methodology in different contexts.
- Published
- 2008